68 related articles for article (PubMed ID: 32798996)
1. Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.
Gibson A; Dave A; Johnson C; Kotwal A; Fingeret AL
J Surg Res; 2020 Dec; 256():486-491. PubMed ID: 32798996
[TBL] [Abstract][Full Text] [Related]
2. Cancer Risk in Graves Disease with Radioactive
Kim KJ; Choi J; Kim KJ; Song E; Yu JH; Kim NH; Yoo HJ; Seo JA; Kim NH; Choi KM; Baik SH; Kim SG
J Nucl Med; 2024 May; 65(5):693-699. PubMed ID: 38548348
[TBL] [Abstract][Full Text] [Related]
3. Prospective study to evaluate radioactive iodine of 20 mCi vs 10-15 mCi in Graves' disease.
Kanokwongnuwat W; Penpong N
BMC Endocr Disord; 2024 Apr; 24(1):54. PubMed ID: 38664774
[TBL] [Abstract][Full Text] [Related]
4. Pediatric Thyroid Carcinoma in Patients with Graves' Disease: The Role of Ultrasound in Selecting Patients for Definitive Therapy.
Kovatch KJ; Bauer AJ; Isaacoff EJ; Prickett KK; Adzick NS; Kazahaya K; Sullivan LM; Mostoufi-Moab S
Horm Res Paediatr; 2015 Apr; ():. PubMed ID: 25896059
[TBL] [Abstract][Full Text] [Related]
5. Risk of Permanent Hypoparathyroidism Requiring Calcitriol Therapy in a Population-Based Cohort of Adults Older Than 65 Undergoing Total Thyroidectomy for Graves' Disease.
Seib CD; Meng T; Cisco RM; Lin DT; McAninch EA; Chen J; Tamura MK; Trickey AW; Kebebew E
Thyroid; 2023 Feb; 33(2):223-229. PubMed ID: 36416252
[No Abstract] [Full Text] [Related]
6. Effect of previous administration of potassium iodine and different durations of low iodine diets for radioiodine therapy on the treatment of Graves' disease in iodine-rich areas.
Tamura M; Nakada K; Iwanaga H; Fujita N; Kato K
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1060-1069. PubMed ID: 38008728
[TBL] [Abstract][Full Text] [Related]
7. The management of pediatric Graves' disease.
Quintanilla-Dieck L
Curr Opin Otolaryngol Head Neck Surg; 2023 Dec; 31(6):419-423. PubMed ID: 37820281
[TBL] [Abstract][Full Text] [Related]
8. MACE and Hyperthyroidism Treated With Medication, Radioactive Iodine, or Thyroidectomy.
Peng CC; Lin YJ; Lee SY; Lin SM; Han C; Loh CH; Huang HK; Pearce EN
JAMA Netw Open; 2024 Mar; 7(3):e240904. PubMed ID: 38436957
[TBL] [Abstract][Full Text] [Related]
9. Trends in radioactive iodine treatment after total thyroidectomy in Italy, 2001-2018.
Dal Maso L; Pierannunzio D; Francisci S; De Paoli A; Toffolutti F; Vaccarella S; Franceschi S; Elisei R; Fedeli U
Eur Thyroid J; 2023 Jul; 12(4):. PubMed ID: 37256604
[TBL] [Abstract][Full Text] [Related]
10. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR
Surgery; 2020 Jan; 167(1):102-109. PubMed ID: 31582311
[TBL] [Abstract][Full Text] [Related]
11. Advancing Preoperative Strategies for Thyroidectomy in Graves' Disease: A Narrative Review.
Elkhoury D; Patel P; Sastry S; Tajik A; Elkhoury C; Montalbano M
Cureus; 2023 Nov; 15(11):e48156. PubMed ID: 38046703
[TBL] [Abstract][Full Text] [Related]
12. Incidental but Not Insignificant: Thyroid Cancer in Patients with Graves Disease.
Wang R; Disharoon M; Song Z; Gillis A; Fazendin J; Lindeman B; Chen H; McMullin JL
J Am Coll Surg; 2024 Apr; 238(4):751-758. PubMed ID: 38230856
[TBL] [Abstract][Full Text] [Related]
13. Characteristics, staging and outcomes of differentiated thyroid cancer in patients with and without Graves' disease.
Gopinath C; Crow H; Panthi S; Bantis L; Burman KD; Choudhary C
J Clin Transl Endocrinol; 2023 Sep; 33():100321. PubMed ID: 37547825
[TBL] [Abstract][Full Text] [Related]
14. Prevalence, Risk Factors, and Clinical and Biochemical Characteristics of Alemtuzumab-Induced Graves Disease.
Ueland GÅ; Ueland HO; Stokland AM; Bhan A; Schønberg A; Sollid ST; Morgas DE; Holmøy T; Lima K; Methlie P; Løvås K; Torkildsen Ø; Husebye ES
J Clin Endocrinol Metab; 2024 Jan; 109(2):344-350. PubMed ID: 37708353
[TBL] [Abstract][Full Text] [Related]
15. Graves' disease in a five-month-old boy with an unusual treatment course.
Azova S; Rajabi F; Modi BP; Mansfield L; Jonas MM; Drobysheva A; Boyd TK; Wassner AJ; Smith JR
J Pediatr Endocrinol Metab; 2021 Mar; 34(3):401-406. PubMed ID: 33675208
[TBL] [Abstract][Full Text] [Related]
16. Hemithyroidectomy versus total thyroidectomy for well differentiated T1-2 N0 thyroid cancer: systematic review and meta-analysis.
Rodriguez Schaap PM; Botti M; Otten RHJ; Dreijerink KMA; Nieveen van Dijkum EJM; Bonjer HJ; Engelsman AF; Dickhoff C
BJS Open; 2020 Oct; 4(6):987-94. PubMed ID: 33022150
[TBL] [Abstract][Full Text] [Related]
17. Treatment and outcome of patients with Graves' disease and metastatic differentiated thyroid cancer.
Besic N; Vidergar-Kralj B
Radiol Oncol; 2023 Sep; 57(3):380-388. PubMed ID: 37665744
[TBL] [Abstract][Full Text] [Related]
18. A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
Villagelin D; Cooper DS; Burch HB
J Clin Endocrinol Metab; 2024 Apr; ():. PubMed ID: 38577717
[TBL] [Abstract][Full Text] [Related]
19. Transient Leukopenia After Radioactive Iodine Treatment in Patients With Graves' Disease: A Retrospective Cohort Study.
Yamashita K; Morimoto S; Kimura S; Seki Y; Bokuda K; Watanabe D; Yazaki T; Abe K; Ichihara A
J Endocr Soc; 2021 May; 5(5):bvab039. PubMed ID: 33928204
[TBL] [Abstract][Full Text] [Related]
20. Machine learning identifies baseline clinical features that predict early hypothyroidism in patients with Graves' disease after radioiodine therapy.
Duan L; Zhang HY; Lv M; Zhang H; Chen Y; Wang T; Li Y; Wu Y; Li J; Li K
Endocr Connect; 2022 May; 11(5):. PubMed ID: 35521803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
